跳至主要内容
临床试验/NCT02475018
NCT02475018已完成不适用

The Effect of Shuhua Milk Fortified With Plant Sterol Esters on Serum Cholesterol in Human

Inner Mongolia Yili Industrial Group Co., Ltd1 个研究点 分布在 1 个国家目标入组 179 人开始时间: 2014年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
179
试验地点
1
主要终点
Change in Total Cholesterol(TC) during and after intervention

研究概览

简要总结

The purpose of this study is to determine whether YiLi Xinhuo Shuhua Milk is effective in reducing the serum cholesterol in human with hypercholesterolemia.

详细描述

In a randomized, placebo-controlled double-blind mono-centric study,179 subjects with total cholesterol (TC) level above 5.18mmol/L and triglyceride (TG) level lower than 2.25mmol/L were assigned to 500ml of low lactose milk enriched with 1.58g plant sterol esters or 500ml plain milk without plant sterols (placebo) or without any dairy product consumption (control) for 60 days. Subjects were instructed to maintain stable diet pattern and physical activity. Plasma concentrations of TC,TG,LDL cholesterol(LDL-C) and HDL cholesterol(HDL-C) were measured at initial visits, after 30days and after 60 days. The primary measurement was the change in TC. Secondary measurements were changes in TG,LDL-C and HDL-C.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female subjects, 18-65 yrs;
  • Serum TC ≥5.18mmol/L, and TG≤2.25mmol/L;
  • Normal blood pressure or able to control blood pressure within normal range;
  • Willing to consent to study participation and to comply with study requirements.

排除标准

  • Pregnant or breastfeeding women;
  • Known allergies to dairy and any substance in the study product.For example lactose intolerance;
  • Any comorbidity that could,in the opinion of the investigator, preclude the subject's ability to successfully and safely complete the study or that may confound study outcomes, including but not limited to cardiac disease, hepatic disease, renal disease, hematopoietic system disease and mental disease;
  • Recent use (within 2 weeks of screening) of any prescription or OTC medication that affects serum total cholesterol or that may confound study outcomes.

结局指标

主要结局

Change in Total Cholesterol(TC) during and after intervention

时间窗: Baseline & 1 months & 2 mongths

次要结局

  • Change in LDL-C level during and after intervention(Baseline & 1 months & 2 mongths)
  • Change in HDL-C level during and after intervention(Baseline & 1 months & 2 mongths)
  • Change in Triglyceride(TG) during and after intervention(Baseline & 1 months & 2 mongths)

研究者

发起方
Inner Mongolia Yili Industrial Group Co., Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验